Welcome to preclinical safety. One of the courses within our series on
drug hunting, the making of new medicines. Since patient safety is
an important consideration, this course emphasizes how promising
molecules are evaluated for safety risks through both in vitro and
in vivo studies. These studies begin during lead selection,
continue into the initiation of clinical research, and even extend
concurrently with clinical trials. We will learn how preclinical safety
studies identify relevant risks a molecule may pose to patients, so
they may be avoided or mitigated, and how safety data guide
clinical dose selection. Through a blend of instructional videos,
selected readings and assessment activities, class participants
will gain in their understanding and appreciation of preclinical safety.